Cdk2 activity has been shown to be selectively up-regulated and that this up-regulation is required for the induction of apoptosis by ginsenoside Rh2 [47], panaxadiol [48], and etoposide [49] in various cancer cell lines. The gene discussed is CDK2; the disease is cancer.